Archive: 21/01/2014

Study examines reasons for delay, denial of new drugs by FDA

Several potentially preventable deficiencies, including failure to select optimal drug doses and suitable outcome measures for a study, accounted for significant delays in the approval of new drugs by the Food and Drug Administration ...

page 2 from 6